By Jennifer Chiou
New York, Nov. 17 - Hansen Medical, Inc. said it raised $30 million from a series C preferred stock offering.
Vanguard Ventures led investors, which included Prospect Venture Partners, Skyline Venture Partners, Thomas Weisel Healthcare Venture Partners, De Novo Ventures and Sapient Capital.
The Hansen Medical technology includes a robotic catheter manipulator, which responds to physicians' commands input to a workstation to allow physicians to place ablation catheters in hard-to-reach anatomical locations within the heart.
"Strong momentum exists in the catheter guidance market place and Hansen Medical is well positioned to become the leader in this space based on its ability to enhance both the speed and safety of catheter-based procedures," Thomas C. McConnell, general partner of Vanguard Ventures, said in a news release.
"This new funding will help us continue to aggressively build our business and, once cleared for sale by the FDA, allow us to launch this exciting new product," said Hansen Medical chief executive officer Frederic Moll said in the release.
"Additionally, the funding will help us continue to explore the vast opportunities for this technology that extend well beyond our initial applications in treating cardiac arrhythmias."
The company said it will use the funds for research and development efforts, as well as the launch and commercialization of the Hansen Robotic Catheter System into the electrophysiology market in 2006.
Based in Mountain View, Calif., Hansen Medical develops technology for catheter movement control during therapeutic procedures. Its patents are principally related to minimally invasive robotic intervention.
| Issuer: | Hansen Medical, Inc.
|
| Issue: | Preferred stock
|
| Amount: | $30 million
|
| Round: | Series C
|
| Investors: | Vanguard Ventures (lead), Prospect Venture Partners, Skyline Venture Partners, Thomas Weisel Healthcare Venture Partners, De Novo Ventures, Sapient Capital
|
| Announcement date: | Nov. 17
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
